Phacilitate Latest News |
Advanced Therapies Week
Overcoming manufacturing challenges for advanced therapies
Manufacturing advanced therapies remains a complex and costly endeavor. In this AT-TV interview from Advanced Therapies Week 2025, Rachel Legmann, Senior Director of Technology at Repligen, explores the persistent challenges in viral vector manufacturing and shares strategies to streamline processes, reduce costs, and enhance scalability for cell and gene therapy developers.
)